Could Bassinet Clearance Expand FDA Authority? Law Firm Expresses Concern
Executive Summary
By clearing Happiest Baby’s SNOO bassinet in March, the US FDA exercised authority over a product that typically would fall within the jurisdiction of consumer product safety regulators. One law firm questions what that might mean for manufacturers of similar products.
You may also be interested in...
SNOO Smart Sleeper Bassinet Wins FDA Clearance
The $1,700 infant sleeper is the first device to reach market indicated to help babies sleep on their backs. It was developed by Happiest Baby.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.